Comparison of two physiotherapy rehabilitation programmes on the exercise capacity in patients with severe pulmonary hypertension

ISRCTN ISRCTN06900747
DOI https://doi.org/10.1186/ISRCTN06900747
Secondary identifying numbers EKBB 200/09
Submission date
27/05/2010
Registration date
15/07/2010
Last edited
15/07/2010
Recruitment status
No longer recruiting
Overall study status
Completed
Condition category
Circulatory System
Prospectively registered
Protocol
Statistical analysis plan
Results
Individual participant data
Record updated in last year

Plain English summary of protocol

Not provided at time of registration

Contact information

Prof Daiana Stolz
Scientific

University Hospital Basel
Pneumology
Petersgraben 4
Basel
4031
Switzerland

Study information

Study designProspective randomised interventional trial
Primary study designInterventional
Secondary study designRandomised controlled trial
Study setting(s)Hospital
Study typeTreatment
Participant information sheet Not available in web format, please use contact details below to request a patient information sheet.
Scientific titleComparison of two physiotherapy rehabilitation programmes on the exercise capacity in patients with severe pulmonary hypertension: a randomised study
Study acronymRehab PH
Study objectivesAn endurance or/and resistance training improves the exercise capacity and quality of life of patients with severe pulmonary hypertension
Ethics approval(s)The local ethics committee, Basel, Switzerland approved in June 2009
Health condition(s) or problem(s) studiedPulmonary hypertension
InterventionIntervention group 1: - endurance training: twice a week, 60 minutes, over 12 weeks
Intervention group 2: - resistance training: twice a week, 60 minutes, over 12 weeks
Intervention typeOther
Primary outcome measureChange in walking distance (6-minutes walk test) after 12 weeks of training and 12 weeks follow up
Secondary outcome measures1. Change in VO2 submax (mobile spiroergometry) after 12 weeks of training and 12 weeks follow up
2. Change in scores for quality of life (SF-36 questionnaire) after 12 weeks of training and 12 weeks follow up
3. Change in scores (MRC-Dyspnoea scale) after 12 weeks of training and 12 weeks follow up
4. Change in daily activity measured with an accelerometer AiperMotion 320 after 12 weeks of training and 12 weeks follow up
Overall study start date01/07/2010
Completion date30/06/2012

Eligibility

Participant type(s)Patient
Age groupAdult
SexBoth
Target number of participants36
Key inclusion criteria1. Patients with pulmonary hypertension diagnosed by right heart catheterisation (mean pulmonary pressure [PAPm] > 25 mmHg)
2. New York Heart Association (NYHA) III - V
3. Walking distance (6-minutes walk test) > 150 meters
4. Patients with stable conditions on PH-related medication (single, double or triple therapy)
5. In stable condition for at least 3 months
Key exclusion criteria1. Skeletal or muscular restrictions which make the training impossible
2. New occurrence of syncope
3. Concomitant neurological diseases
4. Patients with neoplastic diseases
5. Mental disability making a proper evaluation of the study impossible
6. Age > 18 years < 85
7. Rapid fatal disease
Date of first enrolment01/07/2010
Date of final enrolment30/06/2012

Locations

Countries of recruitment

  • Switzerland

Study participating centre

University Hospital Basel
Basel
4031
Switzerland

Sponsor information

University Hospital Basel (Switzerland)
University/education

University Hospital Basel
Pneumology
Petersgraben 4
Basel
4031
Switzerland

ROR logo "ROR" https://ror.org/04k51q396

Funders

Funder type

Hospital/treatment centre

University Hospital Basel (Switzerland) - Clinic of Pneumology and Respiratory Cell Research (from research funds of Prof M Tamm)

No information available

Results and Publications

Intention to publish date
Individual participant data (IPD) Intention to shareNo
IPD sharing plan summaryNot provided at time of registration
Publication and dissemination planNot provided at time of registration
IPD sharing plan